Institutional shares held 1.09 Million
0 calls
0 puts
Total value of holdings $1.3M
$0 calls
$0 puts
Market Cap $178M
149,339,008 Shares Out.
Institutional ownership 0.73%
# of Institutions 3


Latest Institutional Activity in AFMD

Top Purchases

Q4 2023
Ridgeback Capital Investments L.P. Shares Held: 14.9M ($17.7M)
Q4 2023
Morgan Stanley Shares Held: 1.43M ($1.7M)
Q4 2023
Kennedy Capital Management, Inc. Shares Held: 632K ($752K)
Q4 2023
Marshall Wace, LLP Shares Held: 607K ($723K)
Q4 2023
Vestal Point Capital, LP Shares Held: 546K ($650K)

Top Sells

Q4 2023
683 Capital Management, LLC Shares Held: 7M ($8.33M)
Q4 2023
Millennium Management LLC Shares Held: 2.05M ($2.44M)
Q4 2023
Black Rock Inc. Shares Held: 192K ($228K)
Q4 2023
Ubs Oconnor LLC Shares Held: 255K ($303K)
Q4 2023
Two Sigma Investments, LP Shares Held: 632K ($752K)

About AFMD

Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispecific epidermal growth factor receptor, and CD16A-binding innate cell engager, which is in Phase IIa clinical trial for the treatment of advanced cancers; AFM28, an innate cell engager (ICE), which is in preclinical development to treat acute myeloid leukemia; and AFM32, an ICE candidate that is in preclinical development for the treatment of solid tumors. Affimed N.V. has collaboration agreements with The University of Texas MD Anderson Cancer Center; Genentech, Inc.; and Roivant Sciences Ltd., as well as research funding agreement with The Leukemia & Lymphoma Society. The company was formerly known as Affimed Therapeutics B.V. and changed its name to Affimed N.V. in October 2014. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany.


Insider Transactions at AFMD

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on AFMD

Follow Affimed N.V. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AFMD shares.

Notify only if

Insider Trading

Get notified when an Affimed N.V. insider buys or sells AFMD shares.

Notify only if

News

Receive news related to Affimed N.V.

Track Activities on AFMD